ReviewFrontiers in immunology2025

PKM2-driven metabolic reprogramming in digestive system tumors: mechanisms, therapeutic advances, and clinical challenges.

Xinyao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.